CN Patent

CN114585358B — 一种SGLTs/DPP4抑制剂及其应用

Assigned to Dongbao Zixing Hangzhou Biomedical Co ltd · Expires 2023-11-10 · 3y expired

What this patent protects

作为SGLT1/SGLT2/DPP4三重抑制剂的一类化合物，以及在制备作为SGLT1/SGLT2/DPP4三重抑制剂的药物中的应用。具体涉及式(I)所示化合物、其异构体或其药学上可接受的盐。

USPTO Abstract

作为SGLT1/SGLT2/DPP4三重抑制剂的一类化合物，以及在制备作为SGLT1/SGLT2/DPP4三重抑制剂的药物中的应用。具体涉及式(I)所示化合物、其异构体或其药学上可接受的盐。

Drugs covered by this patent

Patent Metadata

Patent number
CN114585358B
Jurisdiction
CN
Classification
—
Expires
2023-11-10
Drug substance claim
No
Drug product claim
No
Assignee
Dongbao Zixing Hangzhou Biomedical Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.